| 2025 |
John, A., Milton, T., Gupta, A., Nguyen, M. T., Stretton, B., Hewitt, J., . . . Callaghan, M. O. (2025). Impact of positive surgical margin location after radical prostatectomy: a network meta-analysis. World Journal of Urology, 43(1), 11 pages.
DOI Scopus4 WoS4 Europe PMC3 |
| 2025 |
Rahman, R., & Selth, L. A. (2025). Cyclin-dependent kinases as mediators of aberrant transcription in prostate cancer. Translational Oncology, 55, 15 pages.
DOI WoS1 |
| 2025 |
Lawrence, M. G., Keerthikumar, S., Townley, S. L., Clark, A. K., Cuffe, G. B., Laven-Law, G., . . . Selth, L. A. (2025). Reprogramming of Androgen Receptor Activity in Castration-resistant Prostate Cancer is Shaped by Truncated Variants.. European urology focus, S2405-4569(25)00073-2.
DOI Scopus2 Europe PMC1 |
| 2025 |
Toubia, J., Kusay, Y., Maqsood, M., Warnock, N. I., Lawrence, D. M., Bracken, C. P., . . . Schreiber, A. W. (2025). TRanscriptome ANalysis of StratifiEd CohorTs (TRANSECT) enables automated assessment of global gene regulation linked to disparate expression in user defined genes and gene sets. NAR Genomics and Bioinformatics, 7(2), lqaf041-1-lqaf041-13.
DOI |
| 2025 |
Xie, J., Shen, K., Liang, W., Kuang, Z., Shrestha, R. K., Hanson, A. R., . . . Selth, L. A. (2025). Protein disulfide isomerases regulate androgen receptor stability and promote prostate cancer cell growth and survival. Proceedings of the National Academy of Sciences of the United States of America, 122(42), e2509222122.
DOI |
| 2024 |
Rollin, S. P. G., Lawrence, M. G., Joshua, A. M., & Selth, L. A. (2024). Friend or foe? Deciphering androgen receptor action to improve bipolar androgen therapy for prostate cancer.. Endocrine-Related Cancer, 32(1), e240208-1-e240208-20.
DOI Scopus1 WoS1 |
| 2024 |
Rahman, R., Rahaman, M. H., Hanson, A. R., Choo, N., Xie, J., Townley, S. L., . . . Selth, L. A. (2024). CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer. British Journal of Cancer, 131(6), 1092-1105.
DOI Scopus3 WoS4 Europe PMC5 |
| 2024 |
Rahman, R., Rahaman, M. H., Hanson, A. R., Choo, N., Xie, J., Townley, S. L., . . . Selth, L. A. (2024). Author Correction: CDK9 inhibition constrains multiple oncogenic transcriptional and epigenetic pathways in prostate cancer.. Br J Cancer, 131(10), 1719.
DOI |
| 2024 |
Neumann, D. P., Phillips, C. A., Lumb, R., Palethorpe, H. M., Ramani, Y., Hollier, B. G., . . . Gregory, P. A. (2024). Quaking isoforms cooperate to promote the mesenchymal phenotype. Molecular biology of the cell, 35(2), ar17-1-ar17-12.
DOI Scopus2 WoS1 Europe PMC2 |
| 2024 |
Neumann, D. P., Pillman, K. A., Dredge, B. K., Bert, A. G., Phillips, C. A., Lumb, R., . . . Gregory, P. A. (2024). The landscape of alternative polyadenylation during EMT and its regulation by the RNA-binding protein Quaking. RNA Biology, 21(1), 1-11.
DOI Scopus8 WoS7 Europe PMC21 |
| 2024 |
Shrestha, R. K., Nassar, Z. D., Hanson, A. R., Iggo, R., Townley, S. L., Dehairs, J., . . . Selth, L. A. (2024). ACSM1 and ACSM3 regulate fatty acid metabolism to support prostate cancer growth and constrain ferroptosis. Cancer Research, 84(14), 2313-2332.
DOI Scopus19 WoS21 Europe PMC17 |
| 2024 |
Wang, Z., Townley, S. L., Zhang, S., Liu, M., Li, M., Labaf, M., . . . Cai, C. (2024). FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer.. Nat Commun, 15(1), 4914.
DOI Scopus15 WoS13 Europe PMC14 |
| 2023 |
Gantley, L., Stringer, B. W., Conn, V. M., Ootsuka, Y., Holds, D., Slee, M., . . . Conn, S. J. (2023). Functional Characterisation of the Circular RNA, circHTT(2-6), in Huntington’s Disease. Cells, 12(9), 1-18.
DOI Scopus6 WoS5 Europe PMC5 |
| 2023 |
Conn, V. M., Gabryelska, M., Toubia, J., Kirk, K., Gantley, L., Powell, J. A., . . . Conn, S. J. (2023). Circular RNAs drive oncogenic chromosomal translocations within the MLL recombinome in leukemia. Cancer Cell, 41(7), 1309-1326.e10.
DOI Scopus45 WoS41 Europe PMC39 |
| 2023 |
O'Callaghan, M. (2023). Re: Addition of Nintedanib or Placebo to Neoadjuvant Gemcitabine and Cisplatin in Locally Advanced Muscle-invasive Bladder Cancer (NEOBLADE): A Double-blind, Randomised, Phase 2 Trial. European Urology, 84(4), 440-441.
DOI |
| 2023 |
Davies, A., Zoubeidi, A., Beltran, H., & Selth, L. A. (2023). The Transcriptional and Epigenetic Landscape of Cancer Cell Lineage Plasticity. Cancer Discovery, 13(8), OF1-OF18.
DOI Scopus61 WoS56 Europe PMC67 |
| 2023 |
Hinneh, J. A., Gillis, J. L., Mah, C. Y., Irani, S., Shrestha, R. K., Ryan, N. K., . . . Butler, L. M. (2023). Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer. British Journal of Cancer, 129(8), 1350-1361.
DOI Scopus9 WoS10 Europe PMC9 |
| 2023 |
Scheinberg, T., Mak, B., Butler, L., Selth, L., & Horvath, L. G. (2023). Targeting lipid metabolism in metastatic prostate cancer. Therapeutic Advances in Medical Oncology, 15, 1-30.
DOI Scopus27 WoS23 Europe PMC26 |
| 2023 |
John, A., Lim, A., Catterwell, R., Selth, L., & O’Callaghan, M. (2023). Length of positive surgical margins after radical prostatectomy: Does size matter? – A systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases, 26(4), 673-680.
DOI Scopus12 WoS13 Europe PMC11 |
| 2023 |
Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (2023). Supplementary Tables S2-S6 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition.
DOI |
| 2023 |
Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (2023). Supplementary Table S1 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition.
DOI |
| 2023 |
Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (2023). Supplementary Figures S1-S6 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition.
DOI |
| 2023 |
Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (2023). Supplementary Figures S1-S6 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition.
DOI |
| 2023 |
Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (2023). Data from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition.
DOI |
| 2023 |
Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (2023). Supplementary Tables S2-S6 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition.
DOI |
| 2023 |
Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (2023). Supplementary Table S1 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition.
DOI |
| 2023 |
Centenera, M. M., Scott, J. S., Machiels, J., Nassar, Z. D., Miller, D. C., Zinonos, I., . . . Butler, L. M. (2023). Data from ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer.
DOI |
| 2023 |
Centenera, M. M., Scott, J. S., Machiels, J., Nassar, Z. D., Miller, D. C., Zinonos, I., . . . Butler, L. M. (2023). Supplementary Data from ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer.
DOI |
| 2023 |
Centenera, M. M., Scott, J. S., Machiels, J., Nassar, Z. D., Miller, D. C., Zinonos, I., . . . Butler, L. M. (2023). Supplementary Data from ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer.
DOI |
| 2022 |
Guo, Z., Yang, C. T., Chien, C. C., Selth, L. A., Bagnaninchi, P. O., & Thierry, B. (2022). Optical Cellular Micromotion: A New Paradigm to Measure Tumor Cells Invasion within Gels Mimicking the 3D Tumor Environments. Small Methods, 6(8), 2200471-1-2200471-13.
DOI Scopus10 WoS10 Europe PMC8 |
| 2022 |
A, M., Owen, K. L., Townley, S., Zanker, D., Rollin, S. P. G., Hanson, A. R., . . . Selth, L. A. (2022). Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate Cancer. Cancer research communications, 2(7), 706-724.
DOI Scopus9 WoS10 Europe PMC8 |
| 2022 |
Abstracts of the Urological Society of Australia and New Zealand Annual Scientific Meeting, 25-28 June 2022, Gold Coast, Australia (2022). BJU International, 129(S2), 4-171.
DOI |
| 2022 |
Abstracts (2022). International Journal of Urology, 29(S1), 5-160.
DOI |
| 2022 |
Posters (2022). BJU International, 129(S2), 62-171.
DOI |
| 2021 |
Xie, J., De Poi, S. P., Humphrey, S. J., Hein, L. K., Bruning, J. B., Pan, W., . . . Proud, C. G. (2021). TSC-insensitive Rheb mutations induce oncogenic transformation through a combination of constitutively active mTORC1 signalling and proteome remodelling. Cellular and Molecular Life Sciences, 78(8), 4035-4052.
DOI Scopus6 WoS6 Europe PMC5 |
| 2021 |
John, A., John, H., Catterwell, R., Selth, L. A., & Callaghan, M. O. (2021). Primary Gleason grade and Gleason grade group at positive surgical margins: a systematic review and meta-analysis. BJU International, 127(S1), 13-22.
DOI Scopus18 WoS18 Europe PMC16 |
| 2021 |
Choo, N., Ramm, S., Luu, J., Winter, J. M., Selth, L. A., Dwyer, A. R., . . . Simpson, K. J. (2021). High-throughput imaging assay for drug screening of 3D prostate cancer organoids. SLAS Discovery, 26(9), 1107-1124.
DOI Scopus55 WoS51 Europe PMC44 |
| 2021 |
Xie, J., Kusnadi, E. P., Furic, L., & Selth, L. A. (2021). Regulation of mRNA translation by hormone receptors in breast and prostate cancer. Cancers, 13(13), 3254-1-3254-26.
DOI Scopus14 WoS14 Europe PMC16 |
| 2021 |
Gillis, J. L., Hinneh, J. A., Ryan, N. K., Irani, S., Moldovan, M., Quek, L. -E., . . . Butler, L. M. (2021). A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth. eLife, 10, e62592-1-e62592-27.
DOI Scopus25 WoS25 Europe PMC27 |
| 2021 |
Davies, A., Nouruzi, S., Ganguli, D., Namekawa, T., Thaper, D., Linder, S., . . . Zoubeidi, A. (2021). An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer.. Nature cell biology, 23(9), 33 pages.
DOI Scopus110 WoS107 Europe PMC116 |
| 2021 |
Che, M., Chaturvedi, A., Munro, S. A., Pitzen, S. P., Ling, A., Zhang, W., . . . Dehm, S. M. (2021). Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer. Nature Communications, 12(1), 6377-1-6377-15.
DOI Scopus21 WoS22 Europe PMC26 |
| 2021 |
Fernandes, R. C., Toubia, J., Townley, S., Hanson, A. R., Dredge, B. K., Pillman, K. A., . . . Selth, L. A. (2021). Post-transcriptional gene regulation by microRNA-194 promotes neuroendocrine transdifferentiation in prostate cancer. Cell Reports, 34(1), 1-17.
DOI Scopus41 WoS40 Europe PMC40 |
| 2021 |
Hickey, T. E., Selth, L. A., Chia, K. M., Laven-Law, G., Milioli, H. H., Roden, D., . . . Tilley, W. D. (2021). The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer. Nature Medicine, 27(2), 310-320.
DOI Scopus182 WoS176 Europe PMC158 |
| 2021 |
Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S., . . . Swinnen, J. V. (2021). Lipidomic profiling of clinical prostate cancer reveals targetable alterations in membrane lipid composition. Cancer Research, 81(19), 4981-4993.
DOI Scopus61 WoS59 Europe PMC56 |
| 2021 |
Centenera, M. M., Scott, J. S., Machiels, J., Nassar, Z. D., Miller, D. C., Zinonos, I., . . . Butler, L. M. (2021). ELOVL5 is a critical and targetable fatty acid elongase in prostate cancer. Cancer Research, 81(7), 1704-1718.
DOI Scopus68 WoS61 Europe PMC65 |
| 2020 |
Davies, A. H., Zoubeidi, A., & Selth, L. A. (2020). The epigenetic and transcriptional landscape of neuroendocrine prostate cancer. Endocrine-Related Cancer, 27(2), R35-R50.
DOI Scopus75 WoS75 Europe PMC72 |
| 2020 |
John, A., O'Callaghan, M., Catterwell, R., & Selth, L. (2020). Does Gleason score of positive surgical margin after radical prostatectomy affect biochemical recurrence and oncological outcomes? Protocol for systematic review. BMJ Open, 10(3), 4 pages.
DOI Scopus4 WoS4 Europe PMC3 |
| 2020 |
Nassar, Z. D., Mah, C. Y., Dehairs, J., Burvenich, I. J., Irani, S., Centenera, M. M., . . . Butler, L. M. (2020). Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis. Elife, 9, 1-34.
DOI Scopus148 WoS143 Europe PMC140 |
| 2020 |
Montgomery, M. K., Bayliss, J., Devereux, C., Bezawork-Geleta, A., Roberts, D., Huang, C., . . . Watt, M. J. (2020). SMOC1 is a glucose-responsive hepatokine and therapeutic target for glycemic control. Science Translational Medicine, 12(559), 1-13.
DOI Scopus46 WoS45 Europe PMC38 |
| 2020 |
18th Urological Association of Asia (UAA) Congress, Leading Urology through Converging Asian Insight, 15-17 October 2020, Seoul, Korea (2020). International Journal of Urology Official Journal of the Japanese Urological Association, 27(S1), 5-165.
DOI |
| 2020 |
Tilley, W., Hickey, T., Selth, L., Chia, K. M., Milioli, H., Laven-Law, G., . . . Carroll, J. (2020). The Androgen Receptor is a Tumour Suppressor in Estrogen Receptor Positive Breast Cancer.
DOI |
| 2019 |
Lorent, J., Kusnadi, E. P., van Hoef, V., Rebello, R. J., Leibovitch, M., Ristau, J., . . . Furic, L. (2019). Translational offsetting as a mode of estrogen receptor α-dependent regulation of gene expression. The EMBO Journal, 38(23), e101323-1-e101323-19.
DOI Scopus29 WoS27 Europe PMC33 |
| 2019 |
Das, R., Feng, F. Y., & Selth, L. A. (2019). Long non-coding RNAs in prostate cancer: biological and clinical implications. Molecular and Cellular Endocrinology, 480, 142-152.
DOI Scopus13 WoS11 Europe PMC10 |
| 2019 |
MacFawn, I., Wilson, H., Selth, L. A., Leighton, I., Serebriiskii, I., Bleackley, R. C., . . . Frisch, S. M. (2019). Grainyhead-like-2 confers NK-sensitivity through interactions with epigenetic modifiers. Molecular Immunology, 105, 137-149.
DOI Scopus24 WoS24 Europe PMC23 |
| 2019 |
Watt, M. J., Clark, A. K., Selth, L. A., Haynes, V. R., Lister, N., Rebello, R., . . . Taylor, R. A. (2019). Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer. Science Translational Medicine, 11(478), 1-12.
DOI Scopus263 WoS251 Europe PMC226 |
| 2019 |
Fernandes, R. C., Hickey, T. E., Tilley, W. D., & Selth, L. A. (2019). Interplay between the androgen receptor signaling axis and microRNAs in prostate cancer. Endocrine-Related Cancer, 26(5), R237-R257.
DOI Scopus22 WoS22 Europe PMC21 |
| 2019 |
Holding, A. N., Giorgi, F. M., Donnelly, A., Cullen, A. E., Nagarajan, S., Selth, L. A., & Markowetz, F. (2019). VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer. Genome Biology, 20(1), 16 pages.
DOI Scopus24 WoS24 Europe PMC27 |
| 2019 |
Holding, A. N., Giorgi, F. M., Donnelly, A., Cullen, A. E., Nagarajan, S., Selth, L. A., & Markowetz, F. (2019). Correction to: VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer (Genome Biol (2019) 20:91 DOI: 10.1186/s13059-019-1698-z). Genome Biology, 20(1), 2 pages.
DOI WoS1 |
| 2019 |
Nassar, Z., Mah, C. Y., Dehairs, J., Burvenich, I. J. G., Irani, S., Centenera, M., . . . Butler, L. (2019). DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis.
DOI |
| 2019 |
Warren, A., Massie, C., Watt, K., Luko, K., Orafidiya, F., Selth, L., . . . Asim, M. (2019). A reciprocal feedback between the PDZ binding kinase and androgen receptor drives prostate cancer. Oncogene, 38(7), 1136-1150.
DOI Scopus19 WoS18 Europe PMC15 |
| 2018 |
Lawrence, M., Obinata, D., Sandhu, S., Selth, L., Wong, S., Porter, L., . . . Frydenberg, M. (2018). Patient-derived models of abiraterone- and enzalutamide-resistant prostate cancer reveal sensitivity to ribosome-directed therapy. European Urology, 74(5), 562-572.
DOI Scopus93 WoS90 Europe PMC80 |
| 2018 |
Matin, F., Jeet, V., Moya, L., Selth, L., Chambers, S., Clements, J., & Batra, J. (2018). A plasma biomarker panel of four MicroRNAs for the diagnosis of prostate cancer. Scientific Reports, 8(1), 6653-1-6653-15.
DOI Scopus74 WoS72 Europe PMC62 |
| 2018 |
Pillman, K. A., Phillips, C. A., Roslan, S., Toubia, J., Dredge, B. K., Bert, A. G., . . . Gregory, P. A. (2018). miR-200/375 control epithelial plasticity-associated alternative splicing by repressing the RNA-binding protein Quaking. EMBO Journal, 37(13), 20 pages.
DOI Scopus87 WoS86 Europe PMC75 |
| 2018 |
Luo, J., Attard, G., Balk, S., Bevan, C., Burnstein, K., Cato, L., . . . Raj, G. (2018). Role of androgen receptor variants in prostate cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting. European Urology, 73(5), 715-723.
DOI Scopus110 WoS109 Europe PMC98 |
| 2018 |
Armstrong, H., Gillis, J., Johnson, I., Nassar, Z., Moldovan, M., Levrier, C., . . . Butler, L. (2018). Dysregulated fibronectin trafficking by Hsp90 inhibition restricts prostate cancer cell invasion. Scientific reports, 8(1), 2090-1-2090-14.
DOI Scopus32 WoS32 Europe PMC29 |
| 2018 |
Dhahbi, J. M., Atamna, H., & Selth, L. A. (2018). Data mining of small RNA-Seq suggests an association between prostate cancer and altered abundance of 5' transfer RNA halves in seminal fluid and prostatic tissues. Biomarkers in cancer, 10, 1-8.
DOI Europe PMC7 |
| 2018 |
Centenera, M., Selth, L., Ebrahimie, E., Butler, L., & Tilley, W. (2018). New opportunities for targeting the androgen receptor in prostate cancer. Cold Spring Harbor Perspectives in Medicine, 10(12), 1-19.
DOI Scopus24 WoS21 Europe PMC20 |
| 2018 |
Holding, A., Giorgi, F., Donnelly, A., Cullen, A., Nagarajan, S., Selth, L., & Markowetz, F. (2018). Network analysis of ChIP-seq data by VULCAN identifies GRHL2 as a key co-regulator of ERa in luminal breast cancer.
DOI Europe PMC1 |
| 2017 |
Das, R., Gregory, P. A., Fernandes, R. C., Denis, I., Wang, Q., Townley, S. L., . . . Selth, L. A. (2017). MicroRNA-194 promotes prostate cancer metastasis by inhibiting SOCS2. Cancer Research, 77(4), 1021-1034.
DOI Scopus101 WoS101 Europe PMC88 |
| 2017 |
Tse, B., Volpert, M., Ratther, E., Stylianou, N., Nouri, M., McGowan, K., . . . Hollier, B. (2017). Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality. Oncogene, 36(24), 3417-3427.
DOI Scopus65 WoS67 Europe PMC59 |
| 2017 |
Miao, L., Yang, L., Li, R., Rodrigues, D., Crespo, M., Hsieh, J., . . . Raj, G. (2017). Disrupting androgen receptor signaling induces Snail-mediated epithelial-mesenchymal plasticity in prostate cancer. Cancer Research, 77(11), 3101-3112.
DOI Scopus71 WoS72 Europe PMC65 |
| 2017 |
Wang, Q., Selth, L., & Callen, D. (2017). MiR-766 induces p53 accumulation and G2/M arrest by directly targeting MDM4. Oncotarget, 8(18), 29914-29924.
DOI Scopus31 WoS33 Europe PMC21 |
| 2017 |
Paltoglou, S., Das, R., Townley, S., Hickey, T., Tarulli, G., Coutinho, I., . . . Selth, L. (2017). Novel androgen receptor coregulator GRHL2 exerts both oncogenic and antimetastatic functions in prostate cancer. Cancer Research, 77(13), 3417-3430.
DOI Scopus81 WoS76 Europe PMC82 |
| 2017 |
Pedraza-Arévalo, S., Hormaechea-Agulla, D., Gómez-Gómez, E., Requena, M., Selth, L., Gahete, M., . . . Luque, R. (2017). Somatostatin receptor subtype 1 as a potential diagnostic marker and therapeutic target in prostate cancer. Prostate, 77(15), 1499-1511.
DOI Scopus36 WoS34 Europe PMC23 |
| 2017 |
Ponnusamy, S., Coss, C., Thiyagarajan, T., Watts, K., Hwang, D. -J., He, Y., . . . Narayanan, R. (2017). Novel selective agents for the degradation of androgen receptor variants to treat castration-resistant prostate cancer. Cancer Research, 77(22), 6282-6298.
DOI Scopus75 WoS72 Europe PMC58 |
| 2017 |
Selth, L., Das, R., Townley, S., Coutinho, I., Hanson, A., Centenera, M., . . . Tilley, W. (2017). A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer. Oncogene, 36(1), 24-34.
DOI Scopus95 WoS94 Europe PMC83 |
| 2017 |
Leach, D. A., Panagopoulos, V., Nash, C., Bevan, C., Thomson, A. A., Selth, L. A., & Buchanan, G. (2017). Cell-lineage specificity and role of AP-1 in the prostate fibroblast androgen receptor cistrome. Molecular and Cellular Endocrinology, 439(C), 261-272.
DOI Scopus23 WoS22 Europe PMC25 |
| 2016 |
Coutinho, I., Day, T., Tilley, W., & Selth, L. (2016). Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence. Endocrine-Related Cancer, 23(12), T179-T197.
DOI Scopus156 WoS146 Europe PMC140 |
| 2016 |
Carter, S., Centenera, M., Tilley, W., Selth, L., & Butler, L. (2016). IκBα mediates prostate cancer cell death induced by combinatorial targeting of the androgen receptor. BMC Cancer, 16(1), 141-1-141-13.
DOI Scopus12 WoS11 Europe PMC7 |
| 2016 |
Carter, S. L., Centenera, M. M., Tilley, W. D., Selth, L. A., & Butler, L. M. (2016). Erratum to: IΚBα mediates prostate cancer cell death induced by combinatorial targeting of the androgen receptor.[BMC Cancer. 2016] 16:141. Doi: 10.1186/s12885-016-2188-2.. BMC Cancer, 16(1), 1 page.
DOI Europe PMC1 |
| 2016 |
Hu, D., Selth, L., Tarulli, G., Meech, R., Wijayakumara, D., Chanawong, A., . . . Hickey, T. (2016). Androgen and estrogen receptors in breast cancer coregulate human UDP-glucuronosyltransferases 2B15 and 2B17. Cancer Research, 76(19), 5881-5893.
DOI Scopus51 WoS51 Europe PMC46 |
| 2016 |
Armstrong, H., Koay, Y., Irani, S., Das, R., Nassar, Z., The Australian Prostate Cancer BioResource., . . . Butler, L. (2016). A novel class of Hsp90 C-terminal modulators have pre-clinical efficacy in prostate tumor cells without induction of a heat shock response. Prostate, 76(16), 1546-1559.
DOI Scopus23 WoS23 Europe PMC21 |
| 2016 |
Roberts, M. J., Richards, R., Chow, C. W. K., Schirra, H., Buck, M., Selth, L. A., . . . Gardiner, R. A. (2016). PROSTATIC FLUID MRNA AND MICRORNA BIOMARKERS: AN EMERGING PARADIGM FOR NONINVASIVE DIAGNOSIS OF PROSTATE CANCER. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 12, 41. |
| 2016 |
Asim, M., Massie, C., Orafidiya, F., Pértega-Gomes, N., Warren, A., Esmaeili, M., . . . Neal, D. (2016). Choline kinase alpha as an androgen receptor chaperone and prostate cancer therapeutic target. Journal of the National Cancer Institute, 108(5), djv371-1-djv371-13.
DOI Scopus46 WoS45 Europe PMC40 |
| 2015 |
Raj, G. V., Selth, L. A., Day, T. K., & Tilley, W. D. (2015). Evolution of androgen deprivation therapy. Cancer Forum, 39(3), 189-194.
WoS1 |
| 2015 |
Need, E., Selth, L., Trotta, A., Leach, D., Giorgio, L., O'Loughlin, M., . . . Buchanan, G. (2015). The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switching from a Luminal A to a Basal-like subtype. BMC Cancer, 15(1), 791-1-791-17.
DOI Scopus31 WoS28 Europe PMC26 |
| 2015 |
Hickey, T., Irvine, C., Dvinge, H., Tarulli, G., Hanson, A., Ryan, N., . . . Selth, L. (2015). Expression of androgen receptor splice variants in clinical breast cancers. Oncotarget, 6(42), 44728-44744.
DOI Scopus85 WoS78 Europe PMC70 |
| 2015 |
Chan, S., Selth, L., Li, Y., Nyquist, M., Miao, L., Bradner, J., . . . Dehm, S. (2015). Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies. Nucleic Acids Research, 43(12), 5880-5897.
DOI Scopus135 WoS132 Europe PMC126 |
| 2015 |
Roberts, M., Chow, C., Schirra, H., Richards, R., Buck, M., Selth, L., . . . Gardiner, R. (2015). Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer. The Prostate, 75(5), 539-549.
DOI Scopus36 WoS34 Europe PMC32 |
| 2015 |
Stegeman, S., Moya, L., Selth, L., Spurdle, A., Clements, J., & Batra, J. (2015). A genetic variant of MDM4 influences regulation by multiple microRNAs in prostate cancer. Endocrine-Related Cancer, 22(2), 265-276.
DOI Scopus51 WoS51 Europe PMC47 |
| 2015 |
Roberts, M. J., Richards, R. S., Gardiner, R. A., & Selth, L. A. (2015). Seminal fluid: a useful source of prostate cancer biomarkers?. Biomarkers in Medicine, 9(2), 77-80.
DOI Scopus18 WoS17 Europe PMC15 |
| 2014 |
Hu, D., Hickey, T., Irvine, C., Wijayakumara, D., Lu, L., Tilley, W., . . . MacKenzie, P. (2014). Identification of androgen receptor splice variant transcripts in breast cancer cell lines and human tissues. Hormones and Cancer, 5(2), 61-71.
DOI Scopus59 WoS54 Europe PMC52 |
| 2014 |
Selth, L. A., Roberts, M. J., Chow, C. W. K., Marshall, V. R., Doi, S. A. R., Vincent, A. D., . . . Gardiner, R. A. (2014). Human seminal fluid as a source of prostate cancer-specific microRNA biomarkers. Endocrine-Related Cancer, 21(4), L17-L21.
DOI Scopus37 WoS34 Europe PMC33 |
| 2014 |
Das, R., Gregory, P., Hollier, B., Tilley, W., & Selth, L. (2014). Epithelial plasticity in prostate cancer: principles and clinical perspectives. Trends in Molecular Medicine, 20(11), 643-651.
DOI Scopus22 WoS22 Europe PMC20 |
| 2014 |
Li, X., Roslan, S., Johnstone, C., Wright, J., Bracken, C., Anderson, M., . . . Khew-Goodall, Y. (2014). MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways. Oncogene, 33(31), 4077-4088.
DOI Scopus109 WoS102 Europe PMC98 |
| 2013 |
Trotta, A., Need, E., Selth, L., Chopra, S., Pinnock, C., Leach, D., . . . Buchanan, G. (2013). Knockdown of the cochaperone SGTA results in the suppression of androgen and PI3K/Akt signaling and inhibition of prostate cancer cell proliferation. International Journal of Cancer, 133(12), 2812-2823.
DOI Scopus20 WoS19 Europe PMC20 |
| 2013 |
Selth, L., Townley, S., Bert, A., Stricker, P., Sutherland, P., Horvath, L., . . . Tilley, W. (2013). Circulating microRNAs predict biochemical recurrence in prostate cancer patients. British Journal of Cancer, 109(3), 641-650.
DOI Scopus116 WoS115 Europe PMC100 |
| 2013 |
Larsson, M., Uvell, H., Sandstrom, J., Ryden, P., Selth, L., & Bjorklund, S. (2013). Functional studies of the yeast Med5, Med15 and Med16 mediator tail subunits. PLoS One, 8(8), e73137-1-e73137-10.
DOI Scopus16 WoS15 Europe PMC15 |
| 2013 |
Sapre, N., & Selth, L. (2013). Circulating microRNAs as biomarkers of prostate cancer: the state of play. Prostate Cancer, 2013, 1-10.
DOI WoS42 Europe PMC41 |
| 2013 |
Gillis, J., Selth, L., Centenera, M., Townley, S., Sun, S., Plymate, S., . . . Butler, L. (2013). Constitutively-active androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitors. Oncotarget, 4(5), 691-704.
DOI Scopus50 WoS48 Europe PMC43 |
| 2013 |
Chiam, K., Ryan, N., Ricciardelli, C., Day, T., Buchanan, G., Ochnik, A., . . . Bianco-Miotto, T. (2013). Characterization of the prostate cancer susceptibility gene KLF6 in human and mouse prostate cancers. Prostate, 73(2), 182-193.
DOI Scopus15 WoS13 Europe PMC12 |
| 2012 |
Need, E., Selth, L., Harris, T., Birrell, S., Tilley, W., & Buchanan, G. (2012). Research resource: interplay between the genomic and transcriptional networks of androgen receptor and estrogen receptor α in luminal breast cancer cells. Molecular Endocrinology, 26(11), 1941-1952.
DOI Scopus76 WoS71 Europe PMC70 |
| 2012 |
Trotta, A., Need, E., Butler, L., Selth, L., O'Loughlin, M., Coetzee, G., . . . Buchanan, G. (2012). Subdomain structure of the co-chaperone SGTA and activity of its androgen receptor client. Journal of Molecular Endocrinology, 49(2), 57-68.
DOI Scopus19 WoS17 Europe PMC17 |
| 2012 |
Moore, N., Buchanan, G., Harris, J., Selth, L., Bianco-Miotto, T., Hanson, A., . . . Tilley, W. (2012). An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activity. Endocrine-Related Cancer, 19(4), 599-613.
DOI Scopus48 WoS47 Europe PMC39 |
| 2012 |
Selth, L., Tilley, W., & Butler, L. (2012). Circulating microRNAs: macro-utility as markers of prostate cancer?. Endocrine-Related Cancer, 19(4), 99-113.
DOI Scopus39 WoS34 Europe PMC32 |
| 2012 |
Thompson, V., Day, T., Bianco-Miotto, T., Selth, L., Han, G., Thomas, M., . . . Tilley, W. (2012). A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease. International Journal of Cancer, 131(3), 662-672.
DOI Scopus33 WoS31 Europe PMC28 |
| 2012 |
Selth, L., Townley, S., Gillis, J., Ochnik, A., Murti, K., Macfarlane, R., . . . Butler, L. (2012). Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease. International Journal of Cancer, 131(3), 652-661.
DOI Scopus164 WoS152 Europe PMC132 |
| 2011 |
Kumar, R., Selth, L., Schulz, R., Tay, B., Neilsen, P., & Callen, D. (2011). Genome-wide mapping of ZNF652 promoter binding sites in breast cancer cells. Journal of Cellular Biochemistry, 112(10), 2742-2747.
DOI Scopus18 WoS16 Europe PMC19 |
| 2011 |
Selth, L. A., Randles, J. W., & Ali Rezaian, M. (2011). Erratum: Agrobacterium tumefaciens supports DNA replication of diverse geminivirus types (FEBS Letters (2002) 516 (179-182)). FEBS Letters, 585(24), 4030.
DOI |
| 2010 |
Selth, L., Sigurdsson, S., & Svejstrup, J. (2010). Transcript elongation by RNA polymerase II. Annual Review of Biochemistry, 79(1), 271-293.
DOI Scopus144 WoS143 Europe PMC140 |
| 2010 |
Kainov, D., Selth, L., Svejstrup, J., Egly, J., & Poterzsman, A. (2010). Interacting partners of the Tfb2 subunit from yeast TFIIH. DNA Repair, 9(1), 33-39.
DOI Scopus11 WoS11 Europe PMC10 |
| 2009 |
Selth, L., Lorch, Y., Ocampo-Hafalla, M., Mitter, R., Shales, M., Krogan, N., . . . Svejstrup, J. (2009). An Rtt109-independent role for Vps75 in transcription-associated nucleosome dynamics. Molecular and Cellular Biology, 29(15), 4220-4234.
DOI Scopus26 WoS25 Europe PMC27 |
| 2009 |
Selth, L., Gilbert, C., & Svejstrup, J. (2009). RNA immunoprecipitation to determine RNA-protein associations in vivo. Cold Spring Harbor Protocols, 4(6), 1-7.
DOI Scopus52 Europe PMC50 |
| 2009 |
Greenwood, C., Selth, L., Dirac-Svejstrup, A., & Svejstrup, J. (2009). An Iron-Sulfur Cluster Domain in Elp3 Important for the Structural Integrity of Elongator. Journal of Biological Chemistry, 284(1), 141-149.
DOI Scopus55 WoS44 Europe PMC44 |
| 2009 |
Eini Gandomani, O., Dogra, S., Selth, L., Dry, I., Randles, J., & Rezaian, M. (2009). Interaction with a Host Ubiquitin-Conjugating Enzyme Is Required for the Pathogenicity of a Geminiviral DNA beta Satellite. Molecular Plant-Microbe Interactions, 22(6), 737-746.
DOI Scopus83 WoS70 Europe PMC56 |
| 2007 |
Selth, L., & Svejstrup, J. (2007). Vps75, a new yeast member of the NAP histone chaperone family. Journal of Biological Chemistry, 282(17), 12358-12362.
DOI Scopus65 WoS64 Europe PMC63 |
| 2006 |
Selth, L., Dogra, S., Rasheed, M., Randles, J., & Rezaian, M. (2006). Identification and characterization of a host reversibly glycosylated peptide that interacts with the Tomato leaf curl virus V1 protein. Plant Molecular Biology, 61(1-2), 297-310.
DOI Scopus27 WoS23 Europe PMC17 |
| 2006 |
Rasheed, M., Selth, L., Koltunow, A., Randles, J., & Rezaian, M. (2006). Single-stranded DNA of Tomato leaf curl virus accumulates in the cytoplasm of phloem cells. Virology, 348(1), 120-132.
DOI Scopus26 WoS24 Europe PMC22 |
| 2005 |
Selth, L., Dogra, S., Rasheed, M., Healy, H., Randles, J., & Rezaian, M. (2005). A NAC domain protein interacts with tomato leaf curl virus replication accessory protein and enhances viral replication. Plant Cell, 17(1), 311-325.
DOI Scopus177 WoS146 Europe PMC116 |
| 2004 |
Selth, L., Randles, J., & Rezaian, M. (2004). Host responses to transient expression of individual genes encoded by Tomato leaf curl virus. Molecular Plant-Microbe Interactions, 17(1), 27-33.
DOI Scopus48 WoS40 Europe PMC36 |
| 2002 |
Selth, L., Randles, J., & Rezaian, M. (2002). Agrobacterium tumefaciens supports DNA replication of diverse geminivirus types. FEBS Letters, 516(1-3), 179-182.
DOI Scopus25 WoS27 Europe PMC24 |
